Inspire Medical Systems, Inc. (NYSE:INSP) Shares Sold by XTX Topco Ltd

XTX Topco Ltd trimmed its holdings in Inspire Medical Systems, Inc. (NYSE:INSP) by 8.9% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,257 shares of the company’s stock after selling 221 shares during the period. XTX Topco Ltd’s holdings in Inspire Medical Systems were worth $359,000 as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. SG Americas Securities LLC raised its position in shares of Inspire Medical Systems by 14.7% in the 1st quarter. SG Americas Securities LLC now owns 4,055 shares of the company’s stock valued at $646,000 after purchasing an additional 521 shares in the last quarter. GAMMA Investing LLC increased its holdings in shares of Inspire Medical Systems by 253.7% in the 1st quarter. GAMMA Investing LLC now owns 573 shares of the company’s stock valued at $91,000 after acquiring an additional 411 shares during the last quarter. New York State Teachers Retirement System increased its holdings in shares of Inspire Medical Systems by 132.7% in the 1st quarter. New York State Teachers Retirement System now owns 21,390 shares of the company’s stock valued at $3,407,000 after acquiring an additional 12,196 shares during the last quarter. Bessemer Group Inc. increased its holdings in shares of Inspire Medical Systems by 1.7% in the 1st quarter. Bessemer Group Inc. now owns 7,183 shares of the company’s stock valued at $1,145,000 after acquiring an additional 123 shares during the last quarter. Finally, Parallel Advisors LLC increased its holdings in shares of Inspire Medical Systems by 356.5% in the 1st quarter. Parallel Advisors LLC now owns 210 shares of the company’s stock valued at $33,000 after acquiring an additional 164 shares during the last quarter. 94.91% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages have recently weighed in on INSP. Piper Sandler set a $150.00 price target on Inspire Medical Systems and gave the company an “overweight” rating in a report on Tuesday, August 5th. KeyCorp downgraded Inspire Medical Systems from an “overweight” rating to a “sector weight” rating in a report on Tuesday, August 5th. Robert W. Baird boosted their price target on Inspire Medical Systems from $230.00 to $236.00 and gave the company an “outperform” rating in a report on Tuesday, May 6th. Wells Fargo & Company lowered their price target on Inspire Medical Systems from $174.00 to $101.00 and set an “equal weight” rating for the company in a report on Tuesday, August 5th. Finally, Lake Street Capital set a $150.00 price target on Inspire Medical Systems and gave the company a “buy” rating in a report on Tuesday, August 5th. Seven equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $173.31.

Inspire Medical Systems Price Performance

Shares of INSP opened at $79.18 on Friday. Inspire Medical Systems, Inc. has a 12 month low of $73.92 and a 12 month high of $225.00. The company has a market cap of $2.34 billion, a P/E ratio of 45.77, a PEG ratio of 2.44 and a beta of 1.22. The stock has a fifty day moving average price of $126.77 and a 200 day moving average price of $151.63.

Inspire Medical Systems (NYSE:INSP) last issued its quarterly earnings results on Monday, August 4th. The company reported $0.45 EPS for the quarter, beating analysts’ consensus estimates of $0.22 by $0.23. The company had revenue of $217.09 million for the quarter, compared to analyst estimates of $214.50 million. Inspire Medical Systems had a return on equity of 10.38% and a net margin of 6.17%. The company’s quarterly revenue was up 10.8% compared to the same quarter last year. During the same period last year, the company earned $0.32 earnings per share. As a group, research analysts anticipate that Inspire Medical Systems, Inc. will post 2.16 earnings per share for the current year.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.